Results 251 to 260 of about 381,302 (291)

Ubiquitin-centered post-translational modification crosstalk orchestrates tumor immunity and immunotherapy response. [PDF]

open access: yesExp Hematol Oncol
Qiao K   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment

Nature Medicine, 2018
The ubiquitin-proteasome system (UPS) comprises a network of enzymes that is responsible for maintaining cellular protein homeostasis. The therapeutic potential of this pathway has been validated by the clinical successes of a number of UPS modulators, including proteasome inhibitors and immunomodulatory imide drugs (IMiDs). Here we identified TAK-243 (
Marc L Hyer   +2 more
exaly   +4 more sources

Structure of the ubiquitin-activating enzyme loaded with two ubiquitin molecules

Acta Crystallographica Section D: Biological Crystallography, 2014
The activation of ubiquitin by the ubiquitin-activating enzyme Uba1 (E1) constitutes the first step in the covalent modification of target proteins with ubiquitin. This activation is a three-step process in which ubiquitin is adenylated at its C-terminal glycine, followed by the covalent attachment of ubiquitin to a catalytic cysteine residue of Uba1 ...
Hermann Schindelin
exaly   +3 more sources

Total Synthesis of the Ubiquitin‐Activating Enzyme Inhibitor (+)‐Panepophenanthrin.

ChemInform, 2003
AbstractFor Abstract see ChemInform Abstract in Full Text.
Xiaoguang, Lei   +2 more
openaire   +2 more sources

E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions.

Clinica chimica acta; international journal of clinical chemistry, 2019
Despite the medical advances of the 21st century, the incidence of cancer continues to increase and the search for a universal cure remains a major health challenge.
S. M. Hosseini   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy